Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
CPEX Pharmaceuticals, Inc. (CPEX) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/05/2011 BW CPEX Completes Sale to FCB I Holdings
03/24/2011 BW CPEX Stockholders Approve $27.25 Per Share Merger Agreement with FCB I Holdings
03/23/2011 BW CPEX Urges Stockholders to Consider the Facts of the Certain All-Cash FCB Transaction
03/18/2011 BW CPEX Pharmaceuticals Affirms Recommendation That Stockholders Vote for Merger Agreement With FCB
03/17/2011 BW CPEX Pharmaceuticals Advises Stockholders to Take No Action at This Time in Response to Mangrove Partners' Revised Proposal
03/17/2011 BW CPEX Pharmaceuticals Continues to Recommend That Stockholders Vote for the Merger Agreement with FCB
03/15/2011 BW CPEX Pharmaceuticals Advises Stockholders to Take No Action at This Time in Response to Mangrove Partners' Proposal
03/11/2011 BW ISS Proxy Advisory Services Recommends That CPEX Stockholders Vote for Merger Agreement with FCB I Holdings
03/04/2011 BW CPEX Receives Letter from Athyrium Capital Management
03/02/2011 BW CPEX Sends Letter to Stockholders
11/08/2010 BW CPEX Pharmaceuticals Reports Third-Quarter 2010 Financial Results
09/29/2010 BW CPEX Announces Continuation of Strategic Alternatives Review Process
08/09/2010 BW CPEX Pharmaceuticals Reports Second-Quarter 2010 Financial Results
05/06/2010 BW CPEX Pharmaceuticals Board of Directors Unanimously Recommends Shareholders Reject Tender Offer Announced by Richard Rofé
05/05/2010 BW CPEX Pharmaceuticals Reports First-Quarter 2010 Financial Results
04/30/2010 BW CPEX Pharmaceuticals Appoints Robert Forrester to Board of Directors
04/23/2010 BW CPEX Pharmaceuticals Advises Shareholders to Take No Action at This Time in Response to Arcadia Unsolicited Tender Offer
03/18/2010 BW CPEX Pharmaceuticals Files Preliminary Proxy Materials and Nominates Highly Qualified Independent Board Candidate for Election at 2010 Annual Meeting
03/17/2010 BW CPEX Pharmaceuticals Announces Preliminary Results from its Phase 2a Clinical Trial of Nasulin™
03/03/2010 BW CPEX Pharmaceuticals Reports 2009 Fourth-Quarter and Year-End Financial Results
02/18/2010 BW CPEX Pharmaceuticals Announces Arcadia Opportunity Master Fund Withdraws Previously Stated Intention to Submit Shareholder Proposals and Nominate Director Slate at 2010 Annual Meeting

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy